In re Ribozyme Pharmaceuticals, Inc. Securities Litigation
District Court, D. Colorado
1Opinion of the Court
MEMORANDUM OPINION AND ORDER
BABCOCK, District Judge.
This Order comes upon cross-motions for appointment of lead plaintiffs and lead counsel. Oral argument was heard on April 20, 2000. For the reasons set forth below, I grant the “Ribozyme Shareholders Group’s” motion for appointment of lead plaintiffs and lead counsel. The lead plaintiffs, therefore, are Mark Adler, Mitchell Gilbert, Barbara Brierre, and David Fasse/Jaqueline Jackson (jointly). Accordingly, I deny the motion of the “Ribozyme Lead Plaintiffs.”
I. Background
This is a class action on behalf of all persons who purchased or…
2Cases cited9 opinions
- Andrews v. Bechtel Power Corp.Court of Appeals for the First Circuit · 1985
- Adamson v. BowenCourt of Appeals for the Tenth Circuit · 1988
- In Re Olsten Corp. Securities Litig.District Court, E.D. New York · 1998
- Chill v. Green Tree Financial Corp.District Court, D. Minnesota · 1998
- Bayles v. American Medical Response of Colorado, Inc.District Court, D. Colorado · 1996
4 more not listed; retrieve them via the Exa API.
3Cited by25 opinions
- Varghese v. China Shenghuo Pharmaceutical Holdings, Inc.District Court, S.D. New York · 2008
- Pirelli Armstrong Tire Corp. v. LaBranche & Co.District Court, S.D. New York · 2004
- Foley v. Transocean Ltd.District Court, S.D. New York · 2011
- In Re Ribozyme Pharmaceuticals, Inc. Securities LitigationDistrict Court, D. Colorado · 2002
- Newby v. Enron Corp.District Court, S.D. Texas · 2002
20 more not listed; retrieve them via the Exa API.